Your browser doesn't support javascript.
loading
Use of dairy industry side-stream lactose for tablet manufacturing - proof of concept study.
Karttunen, Anssi-Pekka; Junnila, Atte; Myöhänen, Eetu; Harju, Elina; Xuan, Chee; Okuyucu, Irem Namli; Heininen, Juho; Kivimäki, Satu; Harju, Vilhelmiina; Julkunen, Maarit; Vähäjärvi, Päivi; Mikkonen, Kirsi S; Tomberg, Teemu; Moilanen, Ulla; Strachan, Clare J; Teppo, Jaakko; Tossavainen, Marika; Peltonen, Leena.
Affiliation
  • Karttunen AP; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland. Electronic address: anssi-pekka.karttunen@helsinki.fi.
  • Junnila A; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
  • Myöhänen E; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
  • Harju E; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
  • Xuan C; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
  • Okuyucu IN; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland; Department of Pharmaceutical Technology, Institute of Health Sciences, Anadolu University, Eskisehir, Turkiye.
  • Heininen J; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
  • Kivimäki S; HAMK Bio Research Unit, Häme University of Applied Sciences (HAMK), Hämeenlinna, Finland.
  • Harju V; HAMK Bio Research Unit, Häme University of Applied Sciences (HAMK), Hämeenlinna, Finland.
  • Julkunen M; HAMK Bio Research Unit, Häme University of Applied Sciences (HAMK), Hämeenlinna, Finland.
  • Vähäjärvi P; HAMK Bio Research Unit, Häme University of Applied Sciences (HAMK), Hämeenlinna, Finland.
  • Mikkonen KS; Department of Food and Nutrition, Faculty of Agriculture and Forestry, University of Helsinki, Helsinki, Finland; Helsinki Institute of Sustainability Science (HELSUS), University of Helsinki, Helsinki, Finland.
  • Tomberg T; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
  • Moilanen U; HAMK Bio Research Unit, Häme University of Applied Sciences (HAMK), Hämeenlinna, Finland.
  • Strachan CJ; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
  • Teppo J; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
  • Tossavainen M; HAMK Bio Research Unit, Häme University of Applied Sciences (HAMK), Hämeenlinna, Finland.
  • Peltonen L; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
Int J Pharm ; 660: 124354, 2024 Jul 20.
Article in En | MEDLINE | ID: mdl-38897486
ABSTRACT
During recent years there have been shortages of certain drugs due to problems in raw material supply. These are often related to active ingredients but could also affect excipients. Lactose is one of the most used excipients in tableting and comes in two anomeric and several solid-state forms. The aim of this study was to utilize lactose from a dairy side-stream and compare it against a commercial reference in direct compression. This would be a sustainable option and would secure domestic availability during crises. Two types of lactose, spray-dried and freeze-dried, were evaluated. Lactose was mixed with microcrystalline cellulose in different ratios together with lubricant and glidant, and flowability and tabletability of the formulations was characterized. The fully amorphous and small particle-sized spray-dried lactose flowed inadequately but exhibited good tabletability. The larger particle-sized, freeze-dried lactose exhibited sufficient flow and better tabletability than the commercial reference. However, disintegration and drug release were slower when using the investigational lactose formulations. This was most likely due to remaining milk proteins, especially caseins, in the lactose. Overall, the investigational lactose provides promise for the use of such a side-stream product during crisis situations but enhancing their properties and/or purity would be needed.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tablets / Cellulose / Drug Compounding / Excipients / Drug Liberation / Freeze Drying / Lactose Language: En Journal: Int J Pharm Year: 2024 Document type: Article Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tablets / Cellulose / Drug Compounding / Excipients / Drug Liberation / Freeze Drying / Lactose Language: En Journal: Int J Pharm Year: 2024 Document type: Article Country of publication: Netherlands